
Reviewing the literature it would appear that tumor markers have often flattered to zzso Early promise does not often seem to be borne out in extended zzso Despite apparently high zzso very few markers are capable of assisting in a screening zzso This brief review attempts to put the roles of tumor markers in perspective and explain how their zzso has led to misunderstanding of their potential value in a clinical zzso It also considers the theoretical basis for their use and highlights how misunderstanding of these can lead to flawed studies and zzso 

